Glucotrack, Inc. (GCTK): debt financing — Glucotrack issues $3.6M convertible note at $3M price; ELOC proceeds to repay

Glucotrack, Inc.

Issued $3.6M convertible promissory note for $3M purchase price ($600K OID), no interest, due in 12 months or upon Qualified Financing.
Conversion price floor of $4.87/share; converts into equity of next financing raising ≥$5M.
Simultaneously entered $20M ELOC with Sixth Borough Capital; 100% of ELOC net proceeds repay note pre-stockholder approval, 50% post.
Note is unsecured, no restrictive covenants; standard events of default include bankruptcy.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Glucotrack, Inc. incurred convertible notes of $3,600,000 at no interest maturing twelve (12) month anniversary of the Issue Date, or the date of closing of a Qualified Financing.

Instrument: convertible notes
Principal: $3,600,000
Rate: no interest
Maturity: twelve (12) month anniversary of the Issue Date, or the date of closing of a Qualified Financing
Event: incurrence

Exact text from the filing

On September 12, 2025 (the “ Issue Date ”), Glucotrack, Inc. (the “ Company ”) entered into a Note Purchase Agreement (the “ Note Purchase Agreement ”), with an investor (the “ Investor ”), pursuant to which the Company issued a Convertible Promissory Note (the “ Note ”) to the Investor in the principal amount of $3,600,000 for a purchase price of $3,000,000.

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.98

Glucotrack, Inc. issued $3,600,000 principal amount of convertible note to the Investor for $3,000,000 purchase price.

Security: convertible note
Shares: $3,600,000 principal amount
Purchaser: the Investor
Consideration: $3,000,000 purchase price

Exact text from the filing

On September 12, 2025 (the “ Issue Date ”), Glucotrack, Inc. (the “ Company ”) entered into a Note Purchase Agreement (the “ Note Purchase Agreement ”), with an investor (the “ Investor ”), pursuant to which the Company issued a Convertible Promissory Note (the “ Note ”) to the Investor in the principal amount of $3,600,000 for a purchase price of $3,000,000.

View on SEC.gov

7 debt financings filed in the last 30 days. Browse all debt financings →

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-013290

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.